US Patent 9834533 Process for preparing SGLT2 inhibitors and intermediates thereof

Patent 9834533 was granted and assigned to ScinoPharm Taiwan on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ScinoPharm Taiwan

Current Assignee

ScinoPharm Taiwan

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

98345330

Patent Inventor Names

Tsung-Yu Hsiao0

Jyh-Hsiung Liao0

Date of Patent

December 5, 2017

Patent Application Number

154304090

Date Filed

February 10, 2017

Patent Citations Received

‌

US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

Patent Primary Examiner

‌

Zinna Northington Davis

Patent abstract

The present invention provides processes for preparing SGLT2 inhibitors, such as dapagliflozin and empagliflozin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9834533 Process for preparing SGLT2 inhibitors and intermediates thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API